Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial. [PDF]
Diab N +16 more
europepmc +1 more source
Reply to Rui and Chen: Initial Success: Camlipixant in Refractory Chronic Cough. [PDF]
Smith JA.
europepmc +1 more source
Prevalence and burden of possible refractory chronic cough in four European countries. [PDF]
Domínguez-Ortega J +7 more
europepmc +1 more source
Telehealth group behavioural cough-suppression therapy for refractory chronic cough using a rolling enrolment model. [PDF]
Slovarp LJ +5 more
europepmc +1 more source
Repeat expansions in RFC1 gene in refractory chronic cough. [PDF]
Hirons B +15 more
europepmc +1 more source
Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF). [PDF]
Smith JA +13 more
europepmc +1 more source
Internet-Based Behavioral Cough Suppression Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. [PDF]
Salois JR +6 more
europepmc +1 more source
Unmasking the unexpected: an unusual cause of refractory chronic cough. [PDF]
Wingfield Digby J +4 more
europepmc +1 more source
The Effect of Attentional Manipulation on Cough Reflex Sensitivity in Individuals with Refractory Chronic Cough and Healthy Controls. [PDF]
Salois JR +7 more
europepmc +1 more source
Efficacy and safety of flupentixol-melitracen in patients with refractory chronic cough: a randomised, double-blinded, placebo-controlled clinical trial. [PDF]
Chen Q +8 more
europepmc +1 more source

